NanoPass Technologies, a developer of painless skin delivery solutions for vaccines and large molecules , announced it has recently closed a new round of financing, led by Israel HealthCare Ventures (IHCV), a healthcare-dedicated venture capital fund, with the participation of existing investors. The capital raised will be used to accelerate the market penetration of NanoPass’ applications through additional licenses with pharmaceutical companies. NanoPass is based in Nes Ziona, Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments